121 related articles for article (PubMed ID: 22185962)
21. Effect of DNA demethylation in experimental encapsulating peritoneal sclerosis.
Kim KH; Ryu HM; Oh SH; Oh EJ; Ahn JS; Lee JH; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
Ther Apher Dial; 2014 Dec; 18(6):628-36. PubMed ID: 25256793
[TBL] [Abstract][Full Text] [Related]
22. Effect of bevacizumab, a vascular endothelial growth factor inhibitor, on a rat model of peritoneal sclerosis.
Ada S; Ersan S; Sifil A; Unlu M; Kolatan E; Sert M; Sarioglu S; Yilmaz O; Camsari T
Int Urol Nephrol; 2015 Dec; 47(12):2047-51. PubMed ID: 26433885
[TBL] [Abstract][Full Text] [Related]
23. Curcumin ameliorates peritoneal fibrosis via inhibition of transforming growth factor-activated kinase 1 (TAK1) pathway in a rat model of peritoneal dialysis.
Zhao JL; Zhang T; Shao X; Zhu JJ; Guo MZ
BMC Complement Altern Med; 2019 Oct; 19(1):280. PubMed ID: 31647008
[TBL] [Abstract][Full Text] [Related]
24. Oral supplementation with sulodexide inhibits neo-angiogenesis in a rat model of peritoneal perfusion.
Pletinck A; Van Landschoot M; Steppan S; Laukens D; Passlick-Deetjen J; Vanholder R; Van Biesen W
Nephrol Dial Transplant; 2012 Feb; 27(2):548-56. PubMed ID: 21750165
[TBL] [Abstract][Full Text] [Related]
25. Development of a peritoneal sclerosis rat model using a continuous-infusion pump.
Komatsu H; Uchiyama K; Tsuchida M; Isoyama N; Matsumura M; Hara T; Fukuda M; Kanaoka Y; Naito K
Perit Dial Int; 2008; 28(6):641-7. PubMed ID: 18981396
[TBL] [Abstract][Full Text] [Related]
26. Anti-fibrotic effects of valproic acid in experimental peritoneal fibrosis.
Costalonga EC; de Freitas LJ; Aragone DDSP; Silva FMO; Noronha IL
PLoS One; 2017; 12(9):e0184302. PubMed ID: 28873458
[TBL] [Abstract][Full Text] [Related]
27. Aliskiren ameliorates chlorhexidine digluconate-induced peritoneal fibrosis in rats.
Ke CY; Lee CC; Lee CJ; Subeq YM; Lee RP; Hsu BG
Eur J Clin Invest; 2010 Apr; 40(4):301-9. PubMed ID: 20486991
[TBL] [Abstract][Full Text] [Related]
28. Prevention of early renal injury by mycophenolate mofetil and its mechanism in experimental diabetes.
Wu YG; Lin H; Qi XM; Wu GZ; Qian H; Zhao M; Shen JJ; Lin ST
Int Immunopharmacol; 2006 Mar; 6(3):445-53. PubMed ID: 16428080
[TBL] [Abstract][Full Text] [Related]
29. Elevated expression of HDAC6 in clinical peritoneal dialysis patients and its pathogenic role on peritoneal angiogenesis.
Shi Y; Ni J; Tao M; Ma X; Wang Y; Zang X; Hu Y; Qiu A; Zhuang S; Liu N
Ren Fail; 2020 Nov; 42(1):890-901. PubMed ID: 32862739
[TBL] [Abstract][Full Text] [Related]
30. [Effect of shenshuning recipe on the extracellular matrix accumulation of the peritoneal fibrosis rats].
Yang HT; Shang YC; Cao SL; Dou YT; Huang Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Dec; 33(12):1683-9. PubMed ID: 24517070
[TBL] [Abstract][Full Text] [Related]
31. The effect of rituximab on encapsulated peritoneal sclerosis in an experimental rat model.
Karaköse S; Bal AZ; Eser EP; Duranay M
Turk J Med Sci; 2020 Jun; 50(4):1123-1130. PubMed ID: 32151122
[TBL] [Abstract][Full Text] [Related]
32. Effect of sirolimus on the regression of peritoneal sclerosis in an experimental rat model.
Ceri M; Unverdi S; Dogan M; Unverdi H; Karaca G; Kocak G; Kurultak I; Akbal E; Can M; Duranay M
Int Urol Nephrol; 2012 Jun; 44(3):977-82. PubMed ID: 22528580
[TBL] [Abstract][Full Text] [Related]
33. Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats.
Subeq YM; Ke CY; Lin NT; Lee CJ; Chiu YH; Hsu BG
Cytokine; 2011 Feb; 53(2):223-30. PubMed ID: 21129996
[TBL] [Abstract][Full Text] [Related]
34. Effects of liposome-encapsulated clodronate on chlorhexidine gluconate-induced peritoneal fibrosis in rats.
Kushiyama T; Oda T; Yamada M; Higashi K; Yamamoto K; Oshima N; Sakurai Y; Miura S; Kumagai H
Nephrol Dial Transplant; 2011 Oct; 26(10):3143-54. PubMed ID: 21362737
[TBL] [Abstract][Full Text] [Related]
35. Mizoribine suppresses the progression of experimental peritoneal fibrosis in a rat model.
Takahashi S; Taniguchi Y; Nakashima A; Arakawa T; Kawai T; Doi S; Ito T; Masaki T; Kohno N; Yorioka N
Nephron Exp Nephrol; 2009; 112(2):e59-69. PubMed ID: 19390220
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of matrix metalloproteinase inhibitor ONO-4817 on morphological alterations in chlorhexidine gluconate-induced peritoneal sclerosis rats.
Ro Y; Hamada C; Inaba M; Io H; Kaneko K; Tomino Y
Nephrol Dial Transplant; 2007 Oct; 22(10):2838-48. PubMed ID: 17545675
[TBL] [Abstract][Full Text] [Related]
37. By reducing production of vascular endothelial growth factor octreotide improves the peritoneal vascular alterations induced by hypertonic peritoneal dialysis solution.
Günal AI; Celiker H; Akpolat N; Ustündag B; Duman S; Akcicek F
Perit Dial Int; 2002; 22(3):301-6. PubMed ID: 12227386
[TBL] [Abstract][Full Text] [Related]
38. Beneficial effects of enalapril on chlorhexidine digluconate-induced liver peritoneal fibrosis in rats.
Lee CJ; Subeq YM; Lee RP; Ke CY; Lin NT; Hsu BG
Chin J Physiol; 2011 Aug; 54(4):225-34. PubMed ID: 22129820
[TBL] [Abstract][Full Text] [Related]
39. Impact of rapamycin on peritoneal fibrosis and transport function.
Xu T; Xie JY; Wang WM; Ren H; Chen N
Blood Purif; 2012; 34(1):48-57. PubMed ID: 22922738
[TBL] [Abstract][Full Text] [Related]
40. Itraconazole Attenuates Peritoneal Fibrosis Through Its Effect on the Sonic Hedgehog Signaling Pathway in Mice.
Kim JS; Cho KS; Park SH; Lee SH; Lee JH; Jeong KH; Lee TW
Am J Nephrol; 2018; 48(6):456-464. PubMed ID: 30472702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
